Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Avricore Health Inc (AVCR)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.1600 +0.0100    +6.67%
16:38:00 - Delayed Data. Currency in CAD ( Disclaimer )
  • Volume: 53,800
  • Bid/Ask: 0.1500 / 0.1600
  • Day's Range: 0.1500 - 0.1600
Type:  Equity
Market:  Canada
Avricore Health 0.1600 +0.0100 +6.67%

Avricore Health Company Profile

 
Read the Avricore Health Inc company profile to learn more about the business and the management team. View Avricore Health Inc facts about employee data, company products and services, and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

-

Equity Type

ORD

Avricore Health Inc. engages in the health data and point-of-care technologies business in Canada. It provides HealthTab, a turnkey point-of-care testing platform that turns pharmacies into community point-of-care diagnostic centers. The company has strategic partnerships with Shoppers Drug Marts and Abbott. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.

Contact Information

Address 789 West Pender Street Suite 1120
Vancouver, V6C 1H2
Canada
Phone 604-773-8943
Fax -

Top Executives

Name Age Since Title
Ray Chepsiuk - 2019 Member of Advisory Board
Mark Zhou - 2019 Member of Advisory Board
David M. Hall 70 2016 Independent Chairman of the Board
Hector Bremner 42 2019 CEO & Director
Alan Arnstein 55 2017 Independent Director
Rodger Seccombe 43 2020 CTO & Director
Philippe Ugnat - 2018 Member of Advisory Board
Robert David Sindelar 69 2018 Independent Director
Sherif Guorgui 47 2017 Member of Advisory Board
Christine J. Hrudka - 2023 Independent Director
Thomas W. Teahen - 2023 Independent Director
Sanjeev Goel - 2020 Member of Advisory Board
David Noshad - 2019 Member of Advisory Board
David Huston - 2019 Member of Advisory Board
Sotiris Antoniou - 2019 Member of Advisory Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AVCR Price Commentary

Write your thoughts about Avricore Health Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email